col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


58 Results       Page 1

 [1] 
Elsevier: Journal of Neuroimmunology
  original article Date Title Authors   All Authors
1 [GO] 2023―Nov―21 Hydroxyurea interaction with α7 nicotinic acetylcholine receptor can underlie its therapeutic efficacy upon COVID-19 Olena Lykhmus, Olena Kalashnyk, Raymond Sullivan, Maryna Skok
2 [GO] 2023―Nov―21 Drug-drug interaction between paxlovid and tacrolimus in a patient with myasthenia gravis and SARS-CoV-2 infection Ying Chen, Wenbin Wan, Xiaoying Yao, Yangtai Guan
3 [GO] 2023―Sep―28 Humoral immune response to COVID-19 vaccine in patients with myasthenia gravis Sonja Holm-Yildiz, Tina Dysgaard, Thomas Krag, Britt Stævnsbo Pedersen, Sebastian Rask Hamm, Laura Pérez-Alós, et al. (+15)
4 [GO] 2023―Aug―29 SARS-CoV-2 mRNA vaccination induces an antigen-specific T cell response correlating with plasma interferon-gamma in B cell depleted patients Tyler L. Borko, Ryan Baxter, Berenice Cabrera-Martinez, Eagappanath Thiruppathi, Maite Sabalza, Iswariya Venkataraman, et al. (+13)
5 [GO] 2023―Jun―17 Ablation of microglia following infection of the central nervous system with a neurotropic murine coronavirus infection leads to increased demyelination and impaired remyelination Yuting Cheng, Dominic Ibarra Javonillo, Collin Pachow, Vanessa M. Scarfone, Kellie Fernandez, Craig M. Walsh, et al. (+2)
6 [GO] 2022―Dec―23 Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review Francesca Bosello, Damiano Marastoni, Francesca Benedetta Pizzini, Chiara Zaffalon, Andrea Zuliani, Giulia Turri, et al. (+4)
7 [GO] 2022―Nov―28 Brain stem encephalitis is a rare complication of COVID-19 Marc C. Shamier, Yvette S. Crijnen, Susanne Bogers, Jeroen W. IJpelaar, Juna M. de Vries, Mathieu van der Jagt, et al. (+5)
8 [GO] 2022―Oct―28 Aquaporin-4 IgG neuromyelitis optica spectrum disorder onset after Covid-19 vaccination: Systematic review Ehab Harahsheh, Marcus Callister, Shemonti Hasan, David Gritsch, Cristina Valencia-Sanchez
9 [GO] 2022―Oct―17 Encephalitis, myocarditis, and thrombocytopenia after COVID-19 mRNA vaccination: Clinical and pathophysiological considerations Nicholas G. Kounis, Virginia Mplani, Periklis Dousdampanis, Panagiotis Plotas, Ioanna Koniari
10 [GO] 2022―Aug―02 Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review Parissa Feizi, Kanika Sharma, Shreya R. Pasham, Lalit Nirwan, Joe Joseph, Shruti Jaiswal, Shitiz Sriwastava
11 [GO] 2022―Jul―14 Myelin oligodendrocyte glycoprotein-IgG1 associated disorders (MOGAD) following SARS-CoV-2 infection: A case series Jeffrey Lambe, Marisa P. McGinley, Brandon P. Moss, Yang Mao-Draayer, Roman Kassa, John R. Ciotti, et al. (+2)
12 [GO] 2022―May―08 COVID-19 mRNA vaccine-associated encephalopathy, myocarditis, and thrombocytopenia with excellent response to methylprednisolone: A case report Md Asaduzzaman, Bidrum Purkayastha, M. M. Jahangir Alam, Shishir Ranjan Chakraborty, Soumitra Roy, Nasad Ahmed
13 [GO] 2022―Apr―22 Changes in ganglioside antibody positivity rates during the COVID-19 pandemic Michael K. Racke, Justin K. Niles, Raymond A. Lorenz, Harvey W. Kaufman
14 [GO] 2022―Mar―05 The challenge of diagnosing Guillain-Barre syndrome in patients with COVID-19 in the intensive care unit Pablo Diaz, Marie Leveque, Geoffroy Hautecloque, François Sellal, Olivier Augereau, Livinia Lita, et al. (+7)
15 [GO] 2021―Dec―13 Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab Ivan Adamec, Dunja Rogić, Monika-Gabriele Penz, Carola Braun, Mario Habek
16 [GO] 2021―Dec―09 New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure Karlo Toljan, Moein Amin, Amy Kunchok, Daniel Ontaneda
17 [GO] 2021―Nov―18 Comments on “Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine” by , J Neuroimmunol Céline Caravagna
18 [GO] 2021―Nov―09 A systematic review of cases of CNS demyelination following COVID-19 vaccination Ismail Ibrahim Ismail, Sara Salama
19 [GO] 2021―Oct―21 Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine Juichi Fujimori, Kouichi Miyazawa, Ichiro Nakashima
20 [GO] 2021―Oct―06 Longitudinally extensive transverse myelitis with anti-myelin oligodendrocyte glycoprotein antibodies following SARS-CoV-2 infection Mariana Dias da Costa, Miguel Leal Rato, Diana Cruz, Anabela Valadas, Ana Patrícia Antunes, Luísa Albuquerque
21 [GO] 2021―Sep―29 The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: A report of three post-mortem cases Viviana Falcón Cama, Javier Marín-Prida, Nelson Acosta-Rivero, Emilio F. Acosta, Leonardo Oramas Díaz, Ana V. Casadesús, et al. (+14)
22 [GO] 2021―Sep―17 AstraZeneca COVID-19 vaccine and Guillain-Barre’ Syndrome in Tasmania: A causal link? Wai M. Oo, Pradeep Giri, Aaron De Souza
23 [GO] 2021―Aug―28 Longitudinally extensive transverse myelitis as a sign of multisystem inflammatory syndrome following COVID-19 infection: A pediatric case report Zahra Pourmoghaddas, Atefeh Sadeghizadeh, Seyedeh Zahra Tara, Alireza Zandifar, Hamid Rahimi, Rana Saleh, et al. (+6)
24 [GO] 2021―Aug―28 SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fibre neuropathy Josef Finsterer
25 [GO] 2021―Aug―16 Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case-control study Mario Habek, Gregor Jakob Brecl, Vanja Bašić Kes, Dunja Rogić, Barbara Barun, Tereza Gabelić, et al. (+8)
26 [GO] 2021―Aug―08 COVID-19 in Cladribine-treated patient with multiple sclerosis Nitsan Haham, Adi Vaknin-Dembinsky
27 [GO] 2021―Aug―08 Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature Young Gi Min, Woohee Ju, Ye-Eun Ha, Jae-Jun Ban, Seolah Lee, Jung-Joon Sung, Je-Young Shin
28 [GO] 2021―Jul―31 Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association? Elisa Vegezzi, Sabrina Ravaglia, Gabriele Buongarzone, Paola Bini, Luca Diamanti, Matteo Gastaldi, et al. (+3)
29 [GO] 2021―Jul―27 Acute disseminated encephalomyelitis and COVID-19: A systematic synthesis of worldwide cases Laura Zelada-Ríos, Kevin Pacheco-Barrios, Milagros Galecio-Castillo, Cesar Yamunaqué, Kelvin Álvarez, Ricardo Otiniano-Sifuentes
30 [GO] 2021―Jul―13 Hyperacute reversible encephalopathy related to cytokine storm following COVID-19 vaccine Luca Baldelli, Giulia Amore, Angelica Montini, Ivan Panzera, Simone Rossi, Pietro Cortelli, et al. (+3)
31 [GO] 2021―Jul―10 Commentary: The spectrum of neurological manifestations related to COVID-19 and vaccinations Rohini D. Samudralwar
32 [GO] 2021―Jul―10 Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms Anton Johansson, Mohamed S. Mohamed, Thiago C. Moulin, Helgi B. Schiöth
33 [GO] 2021―Jun―30 Complex movement disorders in SARS-CoV-2 infection induced acute disseminated encephalomyelitis Ritwik Ghosh, Souvik Dubey, Arpan Mandal, Biman Kanti Ray, Julian Benito-León
34 [GO] 2021―Jun―24 A case of longitudinally extensive transverse myelitis following vaccination against Covid-19 Claudia Pagenkopf, Martin Südmeyer
35 [GO] 2021―Jun―12 Innate immunity, inflammation activation and heat-shock protein in COVID-19 pathogenesis Jibrin Danladi, Hemmen Sabir
36 [GO] 2021―Jun―07 Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement Saúl Reyes, Anthony L. Cunningham, Tomas Kalincik, Eva Kubala Havrdová, Noriko Isobe, Julia Pakpoor, et al. (+7)
37 [GO] 2021―Jun―07 New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine Yasser Aladdin, Bader Shirah
38 [GO] 2021―Jun―05 Dimensions of SARS-CoV-2 associated Guillain-Barré syndrome J. Finsterer, R. Ghosh
39 [GO] 2021―May―29 Post-infectious rhombencephalitis after coronavirus-19 infection: A case report and literature review Valerie Jeanneret, Daniel Winkel, Aida Risman, Hang Shi, Grace Gombolay
40 [GO] 2021―May―13 Diagnosing SARS-CoV-2 associated Guillain-Barre syndrome requires cerebro-spinal-fluid studies Josef Finsterer, Fulvio A. Scorza, Carla A. Scorza, Ana C. Fiorini
41 [GO] 2021―May―04 Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients Hannah Kelly, Brent Sokola, Hesham Abboud
42 [GO] 2021―Apr―28 Guillain-Barré syndrome associated with SARS-CoV-2 infection: A case report with long term follow up Nowshin Papri, Shoma Hayat, Asif Mohammed, Md. Nure Alam Afsar, Imran Hasan, Ananna Rahman, et al. (+2)
43 [GO] 2021―Apr―18 Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review Abu Baker Sheikh, Prabal Kumar Chourasia, Nismat Javed, Mehul Kumar Chourasia, Sajid S. Suriya, Shubhra Upadhyay, et al. (+4)
44 [GO] 2021―Apr―16 Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities Homa Pourriyahi, Amene Saghazadeh, Nima Rezaei
45 [GO] 2021―Apr―01 Steroid-responsive, transverse myelitis is a known complication of COVID-19 J. Finsterer
46 [GO] 2021―Feb―21 Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature Maria M. Escobar, Saurabh Kataria, Erum Khan, Roshan Subedi, Medha Tandon, Kirthika Peshwe, et al. (+3)
47 [GO] 2021―Feb―15 COVID-19, HHV6 and MOG antibody: A perfect storm Muruj Jumah, Farah Rahman, Mark Figgie, Ankita Prasad, Anthony Zampino, Ali Fadhil, et al. (+5)
48 [GO] 2020―Nov―11 A case of area postrema variant of neuromyelitis optica spectrum disorder following SARS-CoV-2 infection Ritwik Ghosh, Kaustav De, Devlina Roy, Arpan Mandal, Subrata Biswas, Subhrajyoti Biswas, et al. (+4)
49 [GO] 2020―Nov―07 COVID-19 associated with sensorimotor polyradiculoneuropathy and skin lesions: A case report Reza Boostani, Fariborz Reazai Talab, Naser Tayyebi Meibodi, Fariba Zemorshidi
50 [GO] 2020―Nov―07 SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation Kiandokht Keyhanian, Raffaella Pizzolato Umeton, Babak Mohit, Vahid Davoudi, Fatemeh Hajighasemi, Mehdi Ghasemi
51 [GO] 2020―Sep―25 Covid-19 systemic infection exacerbates pre-existing acute disseminated encephalomyelitis (ADEM) Omar Hussein, Ahmed Abd Elazim, Michel T. Torbey
52 [GO] 2020―Sep―24 COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment Lorenzo Muccioli, Umberto Pensato, Ilaria Cani, Luca Guerra, Federica Provini, Giorgio Bordin, et al. (+4)
53 [GO] 2020―Jul―15 The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia Maria Rosa Ciardi, Maria Antonella Zingaropoli, Patrizia Pasculli, Valentina Perri, Matteo Tartaglia, Serena Valeri, et al. (+3)
54 [GO] 2020―Jul―14 Hemorrhagic encephalopathy associated with COVID-19 Jonathan D. Krett, Gordon A.E. Jewett, Charissa Elton-Lacasse, Kevin Fonseca, Christopher Hahn, Selena Au, Marcus W. Koch
55 [GO] 2020―Jun―20 Guillain-Barré syndrome in a patient infected with SARS-CoV-2, a case report Mohammad Amin Farzi, Hormoz Ayromlou, Naser Jahanbakhsh, Parisa Hadavi Bavil, Abdolali Janzadeh, Farid Karkon Shayan
56 [GO] 2020―May―31 Multiple sclerosis and COVID-19: A great opportunity for databases promoting research and collaboration Michael K. Racke, Scott D. Newsome
57 [GO] 2020―May―29 Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection Marco Chiarini, Simone Paghera, Daniele Moratto, Nicola De Rossi, Mauro Giacomelli, Raffaele Badolato, et al. (+2)
58 [GO] 2020―Mar―04 HLA associations in narcolepsy type 1 persist after the 2009 H1N1 pandemic Mink Schinkelshoek, Rolf Fronczek, Willem Verduijn, Geert Haasnoot, Sebastiaan Overeem, Claire Donjacour, et al. (+4)
 [1] 

58 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec